[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9803541D0 - Treatment of dyspepsia - Google Patents

Treatment of dyspepsia

Info

Publication number
SE9803541D0
SE9803541D0 SE9803541A SE9803541A SE9803541D0 SE 9803541 D0 SE9803541 D0 SE 9803541D0 SE 9803541 A SE9803541 A SE 9803541A SE 9803541 A SE9803541 A SE 9803541A SE 9803541 D0 SE9803541 D0 SE 9803541D0
Authority
SE
Sweden
Prior art keywords
dyspepsia
medicament
xanthophylls
prophylactic
individual
Prior art date
Application number
SE9803541A
Other languages
English (en)
Other versions
SE9803541L (sv
SE524337C2 (sv
Inventor
Aake Lignell
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Priority to SE9803541A priority Critical patent/SE524337C2/sv
Publication of SE9803541D0 publication Critical patent/SE9803541D0/sv
Priority to JP2000576839A priority patent/JP2002527472A/ja
Priority to CA002346647A priority patent/CA2346647C/en
Priority to ES99948969T priority patent/ES2222732T3/es
Priority to US09/463,958 priority patent/US6923967B1/en
Priority to PCT/EP1999/007551 priority patent/WO2000023064A1/en
Priority to DE69918152T priority patent/DE69918152T2/de
Priority to AU62016/99A priority patent/AU763995B2/en
Priority to EP99948969A priority patent/EP1121106B1/en
Priority to AT99948969T priority patent/ATE269065T1/de
Publication of SE9803541L publication Critical patent/SE9803541L/sv
Priority to NO20011667A priority patent/NO330158B1/no
Publication of SE524337C2 publication Critical patent/SE524337C2/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9803541A 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär SE524337C2 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9803541A SE524337C2 (sv) 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
AT99948969T ATE269065T1 (de) 1998-10-16 1999-10-08 Behandlung von verdauungsstörungen
US09/463,958 US6923967B1 (en) 1998-10-16 1999-10-08 Treatment of dyspepsia
CA002346647A CA2346647C (en) 1998-10-16 1999-10-08 Treatment of dyspepsia
ES99948969T ES2222732T3 (es) 1998-10-16 1999-10-08 Tratamiento de la indigestion.
JP2000576839A JP2002527472A (ja) 1998-10-16 1999-10-08 消化不良の処置
PCT/EP1999/007551 WO2000023064A1 (en) 1998-10-16 1999-10-08 Treatment of dyspepsia
DE69918152T DE69918152T2 (de) 1998-10-16 1999-10-08 Behandlung von verdauungsstörungen
AU62016/99A AU763995B2 (en) 1998-10-16 1999-10-08 Treatment of dyspepsia
EP99948969A EP1121106B1 (en) 1998-10-16 1999-10-08 Treatment of indigestion
NO20011667A NO330158B1 (no) 1998-10-16 2001-04-03 Anvendelse av xantofyller

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803541A SE524337C2 (sv) 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär

Publications (3)

Publication Number Publication Date
SE9803541D0 true SE9803541D0 (sv) 1998-10-16
SE9803541L SE9803541L (sv) 2000-04-17
SE524337C2 SE524337C2 (sv) 2004-07-27

Family

ID=20412979

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803541A SE524337C2 (sv) 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär

Country Status (11)

Country Link
US (1) US6923967B1 (sv)
EP (1) EP1121106B1 (sv)
JP (1) JP2002527472A (sv)
AT (1) ATE269065T1 (sv)
AU (1) AU763995B2 (sv)
CA (1) CA2346647C (sv)
DE (1) DE69918152T2 (sv)
ES (1) ES2222732T3 (sv)
NO (1) NO330158B1 (sv)
SE (1) SE524337C2 (sv)
WO (1) WO2000023064A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058064A1 (ja) 2003-12-19 2005-06-30 Menicon Co., Ltd. アスタキサンチン配合ペット用食物
US20090118227A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
WO2014208511A1 (ja) * 2013-06-27 2014-12-31 学校法人同志社 アスタキサンチン含有腸内フローラ改善組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57105145A (en) * 1980-12-23 1982-06-30 Koichi Tanaka Feed additive
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
IL110139A0 (en) 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
US5886053A (en) 1995-02-03 1999-03-23 Basf Aktiengesellschaft Use of carotenoids for producing drugs for the treatment of dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE522246C2 (sv) 1997-02-27 2004-01-27 Astacarotene Ab Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Also Published As

Publication number Publication date
JP2002527472A (ja) 2002-08-27
EP1121106B1 (en) 2004-06-16
DE69918152T2 (de) 2005-07-07
AU763995B2 (en) 2003-08-07
SE9803541L (sv) 2000-04-17
US6923967B1 (en) 2005-08-02
ES2222732T3 (es) 2005-02-01
SE524337C2 (sv) 2004-07-27
EP1121106A1 (en) 2001-08-08
WO2000023064A1 (en) 2000-04-27
NO20011667L (no) 2001-04-03
NO20011667D0 (no) 2001-04-03
NO330158B1 (no) 2011-02-28
CA2346647C (en) 2003-03-11
AU6201699A (en) 2000-05-08
CA2346647A1 (en) 2000-04-27
DE69918152D1 (de) 2004-07-22
ATE269065T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
SE9704693D0 (sv) Method of the prophylactic treatment of mastitis
CN1827766B (zh) 体外细胞的培养方法
DE69815677D1 (de) Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
US6258855B1 (en) Method of retarding and ameliorating carpal tunnel syndrome
RU2409290C2 (ru) Композиции, пригодные для лечения кожных признаков старения
AU5907896A (en) Pharmaceutically active carotenoids
ATE136540T1 (de) Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel
AU6649996A (en) Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
JP4739522B2 (ja) 結合組織の保護、治療及び修復のための作用物質及び方法。
SE9803541D0 (sv) Treatment of dyspepsia
SE9704590L (sv) Sätt att öka produktionen av och förbättra kvaliteten hos sperma
Fuller et al. Aortic connective tissue changes in miniature pigs fed a lipid-rich diet
CA2405479A1 (en) Method of inhibiting the expression of inflammatory cytokines and chemokines
HUP9902421A2 (hu) Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények
CN1393222B (zh) 一种溶解在油脂中的甾醇化合物的组合物的新用途
AU2001278375A1 (en) Composition for pharmaceutical and cosmetic products
JP5063040B2 (ja) 血管新生阻害剤
ES2054058T3 (es) Shigella transformada.
ATE165213T1 (de) Mit morphogen angereicherte nahrungszusammenstellung
KR20200066154A (ko) 홍해삼 추출물을 함유하는 조성물의 제조방법
RU94022334A (ru) Способ лечения и профилактики инвазионных заболеваний
GR1002969B (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε αιωρημα εμβρυικων κυτταρων με δραση ανοσοποιητικης υποκαταστασης και μεθοδος θεραπειας του συνδρομου της επικτητης μολυνσης ανοσοποιητικης ανεπαρκειας (hiv) με τη χρηση αυτου του παρασκευασματος.
HK1009155A (en) Autologous immune cell therapy : cell compositions, methods and applications to treatment of human disease

Legal Events

Date Code Title Description
NUG Patent has lapsed
NUG Patent has lapsed